JonathanJHoganMD
Nephrology • Philadelphia, PAInstructor, Medicine, Columbia University College of Physicians and Surg
Dr. Hogan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce Street
1 Founders
Philadelphia, PA 19104Phone+1 215-662-2638
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Nephrology, 2010 - 2012
University of Pennsylvania Health SystemResidency, Internal Medicine, 2007 - 2010
Perelman School of Medicine at the University of PennsylvaniaClass of 2007
Certifications & Licensure
PA State Medical License 2009 - 2022
NJ State Medical License 2014 - 2021
NY State Medical License 2010 - 2016
Publications & Presentations
PubMed
- 111 citationsManagement and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceBrad H. Rovin, Dawn J. Caster, Daniel C Cattran, Keisha L. Gibson, Jonathan J. Hogan
Kidney International. 2019-02-01 - 55 citationsUrinary Single-Cell Profiling Captures the Cellular Diversity of the Kidney.Amin Abedini, Yuan O. Zhu, Shatakshee Chatterjee, Gabor Halasz, Kishor Devalaraja-Narashimha
Journal of the American Society of Nephrology. 2021-02-02 - 60 citationsIdentifying Outcomes Important to Patients with Glomerular Disease and Their Caregivers.Simon A. Carter, Talia Gutman, Charlotte Logeman, Dan Cattran, Liz Lightstone
Clinical Journal of the American Society of Nephrology. 2020-05-07
Journal Articles
- DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGSHoward Trachtman, Peter Nelson, Abanti Chaudhuri, Jai Radhakrishnan, Olga Zhdanova, Debbie S Gipson, Tarak Srivastava, Kenneth Lieberman, Vimal Kumar Derebail, Jonatha..., Journal of the American Society of Nephrology
Press Mentions
Travere Therapeutics to Host Virtual R&D Day on Wednesday, December 9, 2020December 1st, 2020
ZyVersa Therapeutics Enhances Scientific Advisory Board with Three Esteemed NephrologistsMay 15th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
